CX 2021 Programme

Acute Stroke Challenges - Thursday, 28th April
Venue:   Kensington 1
Time: 13:30 - 15:30 London time (BST)
CX Debate: TCAR is a safe and effective alternative to transfemoral CAS or CEA in the treatment of patients with symptomatic internal carotid artery stenosis

For the motion
Michael Stoner, Rochester Hills, United States

Against the motion
Gert Jan de Borst, Utrecht, Netherlands

CX Debate: Asymptomatic internal carotid artery stenosis should only be performed with a periprocedural 30 day stroke and death rate of 2% or less?

For the motion
Hans-Henning Eckstein, Munich, Germany

Against the motion
TBA

CX Debate: 50-70% symptomatic carotid artery stenosis should be managed with best medical treatment without carotid endarterectomy

For the motion
Alun Davies, London, United Kingdom

Against the motion
TBA

CX Debate: The majority of patients with TIA/ischaemic stroke who have concomitant atrial fibrillation and carotid artery stenosis should be treated with anticoagulation alone

For the motion
Dominick McCabe, Dublin, Ireland

Against the motion
Henrik Sillesen, Copenhagen, Denmark

CX Debate: Dissecting aneurysms should only be treated medically, not with stenting or surgery

For the motion
Gert Jan de Borst, Utrecht, Netherlands

Against the motion
TBA

Risk of stroke in relation to the degree of asymptomatic carotid stenosis: a population-based cohort study, systematic review, and meta-analysis
Speaker:   Dominic Howard, Oxford, United Kingdom
International variation in carotid surgery is huge despite all the randomized trials performed
Speaker:   Maarit Venermo, Helsinki, Finland